Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, announced the appointment ...
Nat Clin Pract Neurol. 2006;2(9):482-493.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback